McKay-Dee Hospital is a not-for-profit health system operated by Intermountain Healthcare. It is located in Ogden, Utah, United States. With 310 licensed beds, it is the 3rd largest hospital in the Intermountain system, and the 4th largest Hospital in Utah.

There are 310 beds in McKay-Dee Hospital Center.

During the past decade, McKay-Dee Hospital Center conducted 94 clinical trials. In the 10-year time frame, 94 clinical trials started and 66 clinical trials were completed, i.e. on average, 70.2% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 34 clinical trials were completed. i.e. 161.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "McKay-Dee Hospital Center" #1 sponsor was "National Cancer Institute (NCI)" with 64 trials, followed by "SWOG Cancer Research Network" with 29 trials sponsored, "Radiation Therapy Oncology Group" with 22 trials sponsored, "Alliance for Clinical Trials in Oncology" with 16 trials sponsored and "NRG Oncology" with 16 trials sponsored. Other sponsors include 50 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "McKay-Dee Hospital Center" #1 collaborator was "National Cancer Institute (NCI)" with 102 trials as a collaborator, "NRG Oncology" with 31 trials as a collaborator, "Radiation Therapy Oncology Group" with 10 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 8 trials as a collaborator and "Canadian Cancer Trials Group" with 7 trials as a collaborator. Other collaborators include 132 different institutions and companies that were collaborators in the rest 107 trials.

According to Clinical.Site data, the most researched conditions in "McKay-Dee Hospital Center" are "Breast Cancer" (13 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Cervical Adenocarcinoma" (6 trials) and "Fallopian Tube Transitional Cell Carcinoma" (6 trials). Many other conditions were trialed in "McKay-Dee Hospital Center" in a lesser frequency.

Most popular intervention types in "McKay-Dee Hospital Center" are "Drug" (144 trials), "Other" (98 trials), "Biological" (64 trials), "Radiation" (63 trials) and "Procedure" (48 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (50 trials), "Quality-of-Life Assessment" (42 trials), "Questionnaire Administration" (23 trials), "Paclitaxel" (20 trials) and "Biospecimen Collection" (16 trials). Other intervention names were less common.

The vast majority of trials in "McKay-Dee Hospital Center" are 142 trials for "All" genders, 46 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "McKay-Dee Hospital Center". undefined are not yet recruiting, 21 are recruiting, 70 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 83 completed trials in McKay-Dee Hospital Center, 3 suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in McKay-Dee Hospital Center, 6 "Phase 1" clinical trials were conducted, 72 "Phase 2" clinical trials and 110 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 10 trials that are defined as “Not Applicable".

McKay-Dee Hospital Center has several departments that took part in Clinical trials: "McKay-Dee Heart Services" - 5 trials